Skip to main content
Fig. 4 | BMC Public Health

Fig. 4

From: Impact of the COVID-19 pandemic on Bordetella pertussis infections in England

Fig. 4

Vaccine coverage for the prenatal pertussis vaccination programme, completed course of Hexavalent vaccine observed at 6 months from ImmForm and completed course of Hexavalent vaccine at 12 months from the COVER collection. † Prenatal pertussis vaccines coverage among pregnant women vaccinated up to 14 weeks prior to delivery. † † Prenatal pertussis vaccines coverage among pregnant women vaccinated up to 16 weeks prior to delivery and excluding miscarriages and stillbirths regardless of gestational age. † † † Prenatal pertussis vaccines coverage among pregnant women vaccinated up to 26 weeks prior to delivery and excluding miscarriages and stillbirths regardless of gestational age. § Hexavalent vaccine coverage for 2014/15 estimates based on monthly extracts from June 2017 to March 2018. §§ Hexavalent vaccine coverage for 2021/22 estimates based on monthly extracts from April 2021 to June 2021

Back to article page